Hikal Ltd

Hikal Ltd

Next 500 2024
+ 9 More
+ 9 More
OVERVIEW
FINANCIALS

About

Hikal, established in 1988, specialises in the life sciences value chain. It caters to companies in the pharmaceuticals, biotech, crop protection, animal health, and specialty chemicals businesses. In addition to providing active pharmaceutical ingredients (APIs) and intermediates, Hikal also offers contract research and custom synthesis facilities through its manufacturing plants in Gujarat and Karnataka. It uses modern technology like gas chromatography, nuclear magnetic resonance spectrometers, and more for its crop protection vertical. Specialty biocides, antimicrobial actives, and additives for paint coatings, leathers, water treatment, and paper are provided by Hikal’s Specialty Chemicals division. Its manufacturing facilities are located in Taloja and Majad in Maharashtra, Panoli in Gujarat, and Jigani in Karnataka, while the R&D activities are carried out in Pune, Maharashtra.

Incorporation Year: 1988
Headquarters: Mumbai
Top Management: Jai Hiremath
Industry: Pharma
Website: www.hikal.com

Featured In Fortune India Ranking

Next 500 India
#251(2024)#125(2023)#47(2022)#80(2021)#115(2020)#150(2019)#293(2018)#330(2017)#299(2016)#382(2015)
#251(2024)#125(2023)#47(2022)#80(2021)#115(2020)#150(2019)#293(2018)#330(2017)#299(2016)#382(2015)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
1,768
(INR Cr)
Net Operating Income
1,785
(INR Cr)
Assets
2,093
(INR Cr)
Profit
70
(INR Cr)
Net Worth
1,188
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
1768
-13.5%
2043
3.0%
1983
15.1%
1724
13.7%
1517
-5.6%
1607
22.0%
1317
31.3%
1003
10.1%
911
3.7%
878
0.4%
875
29.0%
678
-2.7%
697
30.9%
532
-2.2%
544
-1.5%
552
-
Net Operating Income
(INR Cr)
1785
-11.79%
2023
4.13%
1943
12.92%
1720
14.14%
1507
-5.18%
1590
22.65%
1296
27.83%
1014
9.54%
926
6.17%
872
5.14%
829
25.56%
660
-6.70%
708
40.92%
502
-6.80%
539
-5.92%
573
19.48%
Profit
(INR Cr)
70
-11.2%
78
-51.2%
161
20.6%
133
57.7%
84
-18.1%
103
33.5%
77
14.0%
68
64.4%
41
2.0%
40
-36.8%
64
153.1%
25
-45.1%
46
24.3%
37
407.8%
7
-82.0%
40
-
Assets
(INR Cr)
2093
7.3%
1950
8.6%
1796
14.7%
1566
5.7%
1481
3.3%
1433
8.6%
1320
8.5%
1217
12.8%
1079
-1.1%
1091
2.8%
1061
1.7%
1044
7.6%
970
2.8%
944
6.8%
884
-7.7%
957
-
Net Worth
(INR Cr)
1188
4.8%
1133
6.1%
1068
14.4%
933
14.3%
817
8.0%
756
13.0%
669
10.7%
605
32.0%
458
7.5%
426
7.2%
398
16.1%
342
6.4%
322
10.6%
291
5.8%
275
8.4%
254
46.8%
Employee Cost
(INR Cr)
247
10.8%
222
9.4%
203
23.8%
164
5.0%
157
15.4%
136
6.0%
128
9.7%
117
6.4%
110
20.7%
91
13.2%
80
14.4%
70
10.2%
64
8.1%
59
21.4%
49
-4.3%
51
-
Interest Cost
(INR Cr)
56483136525849486260686066443828
Cash & Bank Balance
(INR Cr)
2160493764322716191428157101310
Total Debt
(INR Cr)
818748675610646661635598505547546584533536499582

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 3.9%3.8%8.1%7.7%5.6%6.4%5.9%6.8%4.5%4.6%7.3%3.7%6.6%7.0%1.3%7.3%
Profit As % Of Assets 3.3%4.0%8.9%8.5%5.7%7.2%5.9%5.6%3.8%3.7%6.0%2.4%4.7%3.9%0.8%4.2%
Profit As % Of Networth 5.9%6.9%15.0%14.3%10.3%13.6%11.5%11.2%9.0%9.5%16.1%7.4%14.3%12.7%2.7%16.0%
Interest Cost to EBITDA % 21.1%18.7%9.2%11.2%20.3%19.6%20.3%24.9%34.4%32.9%36.4%44.1%42.1%41.0%32.6%31.6%
Debt to Equity Ratio 0.690.660.630.650.790.870.950.991.101.281.371.701.651.841.812.29
RONW 6.0%7.1%16.0%15.2%12.1%14.5%12.1%12.7%9.3%9.8%17.3%18.8%19.7%13.1%41.2%26.6%
ROCE 7.5%8.2%14.9%15.9%13.4%15.1%12.7%11.7%11.8%12.4%17.6%15.8%16.4%9.8%17.7%12.7%